Real World Evidence Solutions Market

The real-world evidence (RWE) solutions market is projected to reach USD 12.44 billion by 2031 from USD 6.22 billion in 2026, at a CAGR of 14.9% during the forecast period. The RWE solutions market is expanding as regulators, biopharma companies, and healthcare organizations increasingly use real-world data to evaluate the safety, effectiveness, and value of medicines in routine clinical practice. Regulatory acceptance is strengthening demand. In March 2026, the FDA finalized ICH M14 guidance establishing principles for using real-world data in non-interventional studies for medicine safety, while also noting that the recommendations can support effectiveness studies. Europe is similarly building a large-scale RWE infrastructure through DARWIN EU, which by February 2026 had reached 40 data partners across 18 countries, access to data from around 250 million patients, and 88 completed or ongoing studies.

Two dominant strategies are shaping the RWE solutions market: product innovation and strategic collaboration. In May 2026, Truven, a Merative business, launched the MarketScan Partner Ecosystem, expanding MarketScan's RWE capabilities by allowing clients to combine MarketScan's longitudinal claims data with fit-for-purpose external datasets. Further, in April 2026, Regeneron partnered with TriNetX to access de-identified EHR data from ~300 million patients, supporting drug discovery, development, and real-world evidence generation. These alliances have broadened service portfolios, improved operational efficiency, and accelerated the adoption of modern RWE solutions across healthcare organizations. Together, rapid product innovation and targeted collaborations are driving transformation and growth within the global RWE solutions market.

To know about the assumptions considered for the study download the pdf brochure

The major players operating in this market are IQVIA Holdings Inc. (US), Merative (US), Optum Inc. (US), ICON Plc (Ireland), Syneos Health (US), Parexel International Corporation (US), Tata Consultancy Services (India), Oracle (US), Elevance Health (US), and SAS Institute Inc. (US), among others.

IQVIA HOLDING INC. (US)

IQVIA HOLDINGS INC. (US) stands as a prominent global provider of technology solutions, advanced analytics, and clinical research services. The company’s offerings play a crucial role in assisting biotechnology firms, medical device manufacturers, pharmaceutical companies, government agencies, medical researchers, payers, and healthcare stakeholders in gaining profound insights into diseases, human behavior, and scientific advancements. The company possesses vast and varied data infrastructure, granting access to an extensive range of healthcare data, such as electronic health records (EHRs), claims data, and various other real-world datasets. This access helps in providing thorough insights into patient outcomes, treatment patterns, and healthcare utilization. Thus, by leveraging this robust data foundation, the company is pioneering in the RWE solutions market. The company has a base of over 10,000 clients in over 100 countries and is geographically present in North America, Europe, the Asia Pacific, and Africa.

Merative (US)

Merative serves the healthcare industry, supporting providers, payers, life sciences firms, and government entities through its expertise in data, analytics, and technology. Formerly known as IBM Watson Health, Merative transitioned into an independent entity under Francisco Partners in 2022. The company is dedicated to assisting clients in reconstructing information and gaining insights into the populations they serve, ultimately enhancing healthcare delivery, decision-making processes, and overall performance. The company provides RWE solutions, such as the Merative MarketScan Research Databases, Merative MarketScan Commercial Database, and the Merative Explorys EHR Database, facilitating comprehensive analyses for its users.

Optum Inc. (US)

Optum, Inc., a subsidiary of The UnitedHealth Group, Inc., is a diverse healthcare organization that helps individuals live healthier lives and improve the efficiency of the healthcare system. The company has a mission to enhance individuals' well-being and optimize healthcare system efficiency. Through its Optum Insight, the company offers RWE solutions, enabling healthcare systems to effectively manage costs, adhere to compliance requirements, enhance clinical performance, and navigate the dynamic healthcare landscape. These solutions serve payers, care providers, employers, governments, life science companies, and consumers. The company operates across 150 countries spanning North America, Asia Pacific, Europe, Latin America, the Middle East, and Africa.

MARKET RANKING

The ranking of companies in the RWE solutions market has been determined through a market share analysis, conducted after thorough secondary research and validated by primary respondents. This ranking considers parameters such as revenue generated from the RWE solutions market, product portfolio breadth and depth, innovation, and launches. Based on this analysis, the top players leading the market are IQVIA (US), Merative (US), Optum Inc. (US), Syneos Health (US), and ICON plc (Ireland). These companies offer a broad range of capabilities, including real-world data and analytics, RWE study design, observational studies, registries, external control arms, HEOR, regulatory evidence generation, market access, and post-market research, supporting pharmaceutical and biotechnology companies throughout the product lifecycle.

Related Reports:

Real World Evidence Solutions Market by Component [Datasets (Claims, Clinical, Pharmacy, Genomics), Application [Drug/Device Development (Cancer, Cardio, Neuro), Reimbursement], End User (Pharma, Medtech, Payers, Providers), Region - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]